RANI · Rani Therapeutics Holdings, Inc. · Executive Compensation
Market Cap
$105.83M
Shares
139.40M
Volume · Oct 7
130.66K
Avg daily vol (3M)
765.79K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Talat Imran | Chief Executive Officer | $1,052,101 |
| Svai Sanford | Chief Financial Officer | $946,404 |
| Kate McKinley | Chief Business Officer | $943,937 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Talat Imran | Chief Executive Officer | $3,042,245 |
| Svai Sanford | Chief Financial Officer | $1,291,456 |
| Mir Hashim | Chief Scientific Officer | $1,291,456 |
| Kate McKinley | Chief Business Officer | $1,265,456 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Talat Imran | Chief Executive Officer | $5,266,893 |
| Mir Hashim | Chief Scientific Officer | $2,168,326 |
| Svai Sanford | Chief Financial Officer | $2,155,996 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Talat Imran | Chief Executive Officer | $4,311,190 |
| Mir Hashim | Chief Scientific Officer | $2,319,981 |
| Svai Sanford | Chief Financial Officer | $1,984,669 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Talat Imran | Chief Executive Officer | $11,782,823 |
| Mir Hashim | Chief Scientific Officer | $5,007,297 |
| Svai Sanford | Chief Financial Officer | $4,671,684 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Michelle Gilson | Board | Appointed | 2026-08-04 |
| Nicholas M. Maestas | Chief Financial Officer (principal financial officer and principal accounting officer) | Appointed | 2026-06-30 |
| Svai Sanford | Chief Financial Officer | Resigned | 2026-05-15 |
| Vasudev Bailey | member of the Board | Appointed | 2025-10-27 |
| Abraham Bassan | member of the Board | Appointed | 2025-10-27 |
| Maulik Nanavaty | member of the Company's board of directors | Resigned | 2025-10-27 |
| Andrew Farquharson | member of the Company's board of directors | Resigned | 2025-10-27 |
| Laureen DeBuono | member of the Board | Retired | 2025-04-30 |